The Company is a Korea-based company principally engaged in the development, manufacture and distribution of sustained-release medications. The Company mainly produces peptides as drug materials mainly for prostate cancer, hyperpituitarism, diabetes and neurodegenerative disorders. The Company also provides peptide synthesis services. The Company manufactures raw material medicines and some functional cosmetics. The Company distributes its products within domestic market and to overseas markets. The Company was established on November 21, 1997. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on July 22, 2015.
Headquarters
37-24, Yuseong-Daero, 1628Beon-Gil, Yuseong-Gu
Daejeon; Daejeon;
Contact Details: Purchase the Peptron Inc. report to view the information.
Website: http://www.peptron.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service